Valuation: Vineet Laboratories Limited

Market Cap 558M 5.76M 5.07M 4.71M 4.33M 8.12M 8.27M 56.31M 21.96M 272M 21.64M 21.17M 944M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 9.87M 8.68M 8.06M 7.41M 13.9M 14.15M 96.4M 37.6M 466M 37.04M 36.24M 1.62B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
Jul. 21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
May. 29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
Feb. 14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Feb. 07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
Dec. 17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
Nov. 27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
Nov. 27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
Nov. 24 Vineet Laboratories to consider rights issue RE
Nov. 08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
25-09-16 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
25-07-22 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-12 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
24-11-13 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day+2.99%
1 week+4.16%
Current month+13.93%
1 month+13.49%
3 months-9.26%
6 months+17.05%
Current year+4.73%
1 week 35.65
Extreme 35.65
39.27
1 month 31.5
Extreme 31.5
39.27
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
119
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 2020-12-31
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 56 2016-11-09
Director/Board Member 76 2016-11-09
Chairman 73 2020-11-15
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%+4.16%+28.70%-24.84% 7.42M
+0.69%+1.43%+48.44%+156.66% 1,057B
+1.08%+3.72%+53.32%+52.34% 624B
+0.80%+0.99%+34.83%+78.74% 454B
+1.65%+6.46%+34.21%+30.09% 341B
-0.15%+1.98%+36.30%+40.40% 297B
+0.28%+1.14%+16.80%+18.16% 262B
+1.09%-2.39%-27.97%-41.45% 215B
+1.25%-0.02%+20.14%+58.21% 201B
+0.01%-3.99%+15.23%+62.28% 162B
Average +1.05%+0.53%+26.00%+43.06% 361.4B
Weighted average by Cap. +0.82%+1.57%+35.32%+75.80%

Financials

2024 2025
Net sales 1.51K 15.59 13.71 12.74 11.71 21.97 22.36 152.31 59.41 736.34 58.52 57.26 2.55K 769.53 7.95 6.99 6.49 5.97 11.2 11.4 77.64 30.28 375.34 29.83 29.19 1.3K
Net income 10.27M 106K 93.28K 86.66K 79.7K 149K 152K 1.04M 404K 5.01M 398K 390K 17.38M -202M -2.08M -1.83M -1.7M -1.57M -2.94M -2.99M -20.37M -7.95M -98.48M -7.83M -7.66M -342M
Net Debt 441M 4.55M 4M 3.72M 3.42M 6.41M 6.53M 44.46M 17.34M 215M 17.09M 16.72M 746M 397M 4.1M 3.61M 3.35M 3.08M 5.78M 5.89M 40.09M 15.64M 194M 15.41M 15.07M 672M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
26-07-24 38.52 +2.99% 73,138
26-07-23 ₹37.40 +0.19% 50,064
26-07-22 ₹37.33 -1.81% 27,491
26-07-21 ₹38.02 +1.25% 69,575
26-07-20 ₹37.55 +1.54% 25,255
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock